Hüperinsulinaemeuglükeemiline

Hüperinsulinaemeuglükeemiline, a term derived from Greek roots, describes a medical condition characterized by an overproduction of insulin by the pancreas, leading to excessively low blood glucose levels. This state is also known as hyperinsulinism. Insulin is a hormone responsible for regulating blood sugar by allowing cells to absorb glucose from the bloodstream for energy. When the pancreas releases too much insulin, it causes glucose to be removed from the blood too rapidly.

The symptoms of hüperinsulinaemeuglükeemiline can range from mild to severe and often manifest when blood glucose levels drop significantly. Common signs include shakiness, sweating, dizziness, confusion, and irritability. In more severe cases, it can lead to seizures, loss of consciousness, and even coma. Persistent or recurrent episodes can be indicative of an underlying issue.

Causes of hüperinsulinaemeuglükeemiline can be congenital, meaning present from birth, often due to genetic mutations affecting pancreatic beta cells, which produce insulin. Acquired forms can develop later in life, sometimes associated with certain medications, tumors of the pancreas (insulinomas), or post-bariatric surgery. Diagnosis typically involves blood tests to measure glucose and insulin levels, often after a period of fasting or during symptomatic episodes. Treatment strategies depend on the cause and severity, and may include dietary modifications to control carbohydrate intake, medication to reduce insulin production or improve glucose utilization, or surgical intervention in cases of insulinomas.